8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacotherapy for borderline personality disorder--current evidence and recent trends.

      1 ,

      Current psychiatry reports

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Drug treatment of patients with borderline personality disorder (BPD) is common but mostly not supported by evidence from high-quality research. This review summarises the current evidence up to August 2014 and also aims to identify research trends in terms of ongoing randomised controlled trials (RCTs) as well as research gaps. There is some evidence for beneficial effects by second-generation antipsychotics, mood stabilisers and omega-3 fatty acids, while the overall evidence base is still unsatisfying. The dominating role SSRI antidepressants usually play within the medical treatment of BPD patients is neither reflected nor supported by corresponding evidence. Any drug treatment of BPD patients should be planned and regularly evaluated against this background of evidence. Research trends indicate increasing attention to alternative treatments such as dietary supplementation by omega-3 fatty acids or oxytocin.

          Related collections

          Author and article information

          Journal
          Curr Psychiatry Rep
          Current psychiatry reports
          1535-1645
          1523-3812
          Jan 2015
          : 17
          : 1
          Affiliations
          [1 ] Department of Psychiatry and Psychotherapy, University Medical Center Mainz, Untere Zahlbacher Straße 8, 55131, Mainz, Germany, jutta.stoffers@uniklinik-freiburg.de.
          Article
          10.1007/s11920-014-0534-0
          25413640
          474f4577-922a-4620-a244-433d0cd6065e

          Comments

          Comment on this article